Frank S J, Gilliland G, Kraft A S, Arnold C S
Department of Medicine, University of Alabama, Birmingham 35294.
Endocrinology. 1994 Nov;135(5):2228-39. doi: 10.1210/endo.135.5.7956946.
An early step in GH action involves tyrosine phosphorylation of various cellular proteins. Recently, it has been shown in murine preadipocytes that GH promotes the association of its receptor (the GHR) with and the activation of the JAK2 tyrosine kinase. In this study, we confirmed the human (h) GH-induced association of JAK2 with hGHR in IM-9 cells by coimmunoprecipitation experiments using anti-hGHR serum. We further examined the interaction of JAK2 with the GHR cytoplasmic domain by two lines of investigation. For in vitro studies, we assayed by immunoblotting the ability of cell-derived JAK2 to interact with glutathione S-transferase fusion proteins containing elements of the hGHR cytoplasmic domain. A fusion protein containing the entire hGHR cytoplasmic domain (residues 271-620) specifically associated with JAK2 independent of prior stimulation of cells with hGH. This interaction was not dependent on tyrosine phosphorylation of either partner. Mutational analysis of the hGHR cytoplasmic domain component of the fusions indicated that a membrane-proximal 20-residue region that includes the proline-rich box 1 was necessary for the interaction. This region appeared to cooperate with another region(s), largely in the N-terminal one third of the cytoplasmic domain, to promote full interaction with JAK2. For in vivo reconstitution experiments, wild-type (WT) and mutant rabbit GHRs (rGHRs) along with murine JAK2 were expressed by transient transfection in COS-7 cells. rGHR mutations were confined to the cytoplasmic domain and included C-terminal truncations as well as internal deletions of residues 297-406 and 278-292 (the latter contains box 1). All mutant rGHRs were expressed at the cell surface and bound hGH to a degree similar to the WT rGHR. Receptors were tested for their ability to mediate the hGH-induced immunoprecipitability of JAK2 with phosphotyrosine (APT) antibodies. A rGHR truncated to residue 275 [rGHR-(1-275)], which contains only five cytoplasmic residues, failed to mediate JAK2 APT precipitability in response to hGH. In contrast, WT rGHR; the C-terminal truncations rGHR-(1-542), rGHR-(1-390), and rGHR-(1-317); and the rGHR-(d297-406) deletion mutant maintained this ability. Deletion of the 278-292 box 1-containing region in the context of either rGHR-(d297-406) or WT rGHR eliminated detectable hGH-induced JAK2 APT precipitability. Interestingly, rGHR-(1-292), which includes box 1, was not able to mediate significant hGH-induced JAK2 APT precipitability.(ABSTRACT TRUNCATED AT 400 WORDS)
生长激素(GH)作用的早期步骤涉及多种细胞蛋白的酪氨酸磷酸化。最近,在小鼠前脂肪细胞中已表明,GH可促进其受体(GHR)与JAK2酪氨酸激酶的结合及激活。在本研究中,我们通过使用抗hGHR血清的共免疫沉淀实验,证实了人(h)GH诱导IM-9细胞中JAK2与hGHR的结合。我们通过两条研究路线进一步检测了JAK2与GHR胞质结构域的相互作用。对于体外研究,我们通过免疫印迹分析细胞来源的JAK2与含有hGHR胞质结构域元件的谷胱甘肽S-转移酶融合蛋白相互作用的能力。一种包含完整hGHR胞质结构域(第271 - 620位氨基酸)的融合蛋白可独立于hGH对细胞的预先刺激而与JAK2特异性结合。这种相互作用不依赖于任何一方的酪氨酸磷酸化。对融合蛋白中hGHR胞质结构域成分的突变分析表明,一个包含富含脯氨酸的框1的膜近端20个氨基酸区域对于这种相互作用是必需的。该区域似乎与另一个区域(主要在胞质结构域的N端三分之一处)协同作用,以促进与JAK2的充分相互作用。对于体内重组实验,野生型(WT)和突变型兔GHR(rGHR)以及小鼠JAK2通过在COS-7细胞中瞬时转染来表达。rGHR突变局限于胞质结构域,包括C端截短以及第297 - 406位和第278 - 292位氨基酸(后者包含框1)的内部缺失。所有突变型rGHR均在细胞表面表达,并与hGH结合的程度与WT rGHR相似。检测受体介导hGH诱导的JAK2与磷酸酪氨酸(pTyr)抗体免疫沉淀的能力。截短至第275位氨基酸的rGHR [rGHR-(1 - 275)],仅包含五个胞质氨基酸,对hGH无反应,无法介导JAK2的pTyr沉淀。相反,WT rGHR;C端截短的rGHR-(1 - 542)、rGHR-(1 - 390)和rGHR-(1 - 317);以及rGHR-(d297 - 406)缺失突变体保持了这种能力。在rGHR-(d297 - 406)或WT rGHR背景下缺失包含框1的第278 - 292位区域消除了可检测到的hGH诱导的JAK2 pTyr沉淀。有趣的是,包含框1的rGHR-(1 - 292)不能介导显著的hGH诱导的JAK2 pTyr沉淀。(摘要截断于400字)